Anterior and Posterior Pulmonary Cusp Augmentation in the Repair of Tetralogy of Fallot.


Journal

Texas Heart Institute journal
ISSN: 1526-6702
Titre abrégé: Tex Heart Inst J
Pays: United States
ID NLM: 8214622

Informations de publication

Date de publication:
01 09 2022
Historique:
entrez: 12 10 2022
pubmed: 13 10 2022
medline: 15 10 2022
Statut: ppublish

Résumé

In this retrospective study, we compared the results from 2 pulmonary valve augmentation techniques in patients undergoing surgical repair of tetralogy of Fallot. Between 2015 and 2018, 18 patients had anterior pulmonary valve repair at our institution, and 26 patients had both anterior and posterior pulmonary valve repair. Patients ranged from 6 months to 30 years of age. The median follow-up period was 8 months in the anterior augmentation group and 5 months in the anterior and posterior augmentation group. Postoperative echocardiograms indicated that only 2 patients (11%) in the anterior augmentation group had moderate or severe pulmonary insufficiency, compared with no patients in the anterior and posterior augmentation group. At follow-up, pulmonary insufficiency was seen in 3 patients (17%) in the anterior augmentation group and no patients in the anterior and posterior augmentation group. Reconstruction of the native pulmonary valve accompanied by pulmonary cusp augmentation can decrease or even circumvent postoperative pulmonary insufficiency. Both anterior augmentation and anterior and posterior augmentation techniques are easily applied; however, we believe that the anterior and posterior augmentation technique is superior in terms of early postoperative and follow-up pulmonary insufficiency outcomes.

Sections du résumé

BACKGROUND
In this retrospective study, we compared the results from 2 pulmonary valve augmentation techniques in patients undergoing surgical repair of tetralogy of Fallot.
METHODS
Between 2015 and 2018, 18 patients had anterior pulmonary valve repair at our institution, and 26 patients had both anterior and posterior pulmonary valve repair.
RESULTS
Patients ranged from 6 months to 30 years of age. The median follow-up period was 8 months in the anterior augmentation group and 5 months in the anterior and posterior augmentation group. Postoperative echocardiograms indicated that only 2 patients (11%) in the anterior augmentation group had moderate or severe pulmonary insufficiency, compared with no patients in the anterior and posterior augmentation group. At follow-up, pulmonary insufficiency was seen in 3 patients (17%) in the anterior augmentation group and no patients in the anterior and posterior augmentation group.
CONCLUSION
Reconstruction of the native pulmonary valve accompanied by pulmonary cusp augmentation can decrease or even circumvent postoperative pulmonary insufficiency. Both anterior augmentation and anterior and posterior augmentation techniques are easily applied; however, we believe that the anterior and posterior augmentation technique is superior in terms of early postoperative and follow-up pulmonary insufficiency outcomes.

Identifiants

pubmed: 36223246
pii: 487437
doi: 10.14503/THIJ-20-7368
pmc: PMC9632395
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2022 by the Texas Heart® Institute, Houston.

Références

Ann Thorac Surg. 2003 Aug;76(2):555-61; discussion 561
pubmed: 12902102
Asian Cardiovasc Thorac Ann. 2013 Feb;21(1):9-13
pubmed: 23430414
Ann Thorac Surg. 2003 Dec;76(6):1901-5
pubmed: 14667608
J Cardiothorac Surg. 2013 Mar 28;8:55
pubmed: 23537211
Ann Thorac Surg. 2003 Jan;75(1):303-5
pubmed: 12537246

Auteurs

Irfan Tasoglu (I)

Department of Pediatric Cardiovascular Surgery, Ankara City Hospital, Ankara, Turkey.

Basak Soran Turkcan (BS)

Department of Pediatric Cardiovascular Surgery, Ankara City Hospital, Ankara, Turkey.

Naim Boran Tumer (NB)

Department of Cardiovascular Surgery, Ankara City Hospital, Ankara, Turkey.

Atakan Atalay (A)

Department of Pediatric Cardiovascular Surgery, Ankara City Hospital, Ankara, Turkey.

Deniz Eris (D)

Department of Pediatric Cardiology, Ankara City Hospital, Ankara, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH